Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Mattias Neyt

6 Results

2006

An economic evaluation of Herceptin((R)) in adjuvant setting: The Breast Cancer International Research Group 006 trial

Mattias NeytJohan AlbrechtVeronique Cocquyt

A1 Journal Article in ANNALS OF ONCOLOGY

Cost considerations for monoclonal antibody-targeted therapy in cancer: focus on Trastuzumab

A4 Journal Article in AMERICAN JOURNAL OF CANCER

The long-term evolution of quality, of life for disease-free breast cancer survivors : a comparative study in Belgium

Mattias NeytJohan Albrecht

A1 Journal Article in JOURNAL OF PSYCHOSOCIAL ONCOLOGY

2005

Bureaucratisation and the growth of health care expenditures in Europe

Johan AlbrechtMattias NeytTom Verbeke

Comparing the cost of delayed and immediate autologous breast reconstruction in Belgium

Mattias NeytPhillip BlondeelJohan Albrecht

A1 Journal Article in BRITISH JOURNAL OF PLASTIC SURGERY

Cost-effectiveness of Herceptin (R): A standard cost model for breast-cancer treatment in a Belgian university hospital

Mattias NeytJohan AlbrechtBart ClarysseVeronique Cocquyt

A1 Journal Article in INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE